Home > Income Statement > PIRAMAL PHARMA

PIRAMAL PHARMA
Consolidated Net Profit

    Back to Income Statement
PIRAMAL PHARMA is part of below Screeners ↓
Best 1M Momentum Small Cap Stocks
COMMUNITY POLL
for PIRAMAL PHARMA
Please provide your vote to see the results

PIRAMAL PHARMA Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹91 Cr₹18 Cr₹-186 Cr₹376 Cr₹835 Cr

What is the latest Consolidated Net Profit of PIRAMAL PHARMA ?

The latest Consolidated Net Profit ratio of PIRAMAL PHARMA is ₹91 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹91 Cr
Mar2024₹18 Cr
Mar2023₹-186 Cr
Mar2022₹376 Cr
Mar2021₹835 Cr

How is Consolidated Net Profit of PIRAMAL PHARMA Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹91 Cr
411.39
Mar2024 ₹18 Cr
Positive
Mar2023 ₹-186 Cr
Negative
Mar2022 ₹376 Cr
-54.98
Mar2021 ₹835 Cr -

Compare Consolidated Net Profit of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹20,037.7 Cr 1.5% 8.4% -33.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹399,549.0 Cr -1.9% -7.3% -2.2% Stock Analytics
DIVIS LABORATORIES ₹166,862.0 Cr 1.8% 3.3% 9.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹139,912.0 Cr -0.5% -4% 29.9% Stock Analytics
DR REDDYS LABORATORIES ₹101,891.0 Cr 0.2% -4.9% 6.6% Stock Analytics
CIPLA ₹99,591.5 Cr 0.5% -3.8% -17% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

1.5%

8.4%

-33.2%

SENSEX

3.2%

5%

5.5%


You may also like the below Video Courses